VanEck Vectors Performance

BBH -- USA Etf  

USD 128.69  0.41  0.32%

The entity has beta of 0.0156 which indicates as returns on market increase, VanEck Vectors returns are expected to increase less than the market. However during bear market, the loss on holding VanEck Vectors will be expected to be smaller as well.. Although it is vital to follow to VanEck Vectors Biotech current price movements, it is good to be conservative about what you can actually do with the information regarding equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting VanEck Vectors Biotech technical indicators you can presently evaluate if the expected return of 0.3293% will be sustainable into the future.
 Time Horizon     30 Days    Login   to change

VanEck Vectors Biotech Relative Risk vs. Return Landscape

If you would invest  12,066  in VanEck Vectors Biotech ETF on June 16, 2018 and sell it today you would earn a total of  803.00  from holding VanEck Vectors Biotech ETF or generate 6.66% return on investment over 30 days. VanEck Vectors Biotech ETF is generating 0.3293% of daily returns assuming volatility of 1.1891% on return distribution over 30 days investment horizon. In other words, 10% of equities are less volatile than the company and above 94% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, VanEck Vectors Biotech ETF is expected to generate 1.79 times more return on investment than the market. However, the company is 1.79 times more volatile than its market benchmark. It trades about 0.28 of its potential returns per unit of risk. The DOW is currently generating roughly 0.01 per unit of risk.

VanEck Vectors Market Risk Analysis

Sharpe Ratio = 0.277
Good Returns
Average Returns
Small ReturnsBBH
Negative Returns

VanEck Vectors Relative Performance Indicators

Estimated Market Risk
  actual daily
 90 %
of total potential
Expected Return
  actual daily
 6 %
of total potential
Risk-Adjusted Return
  actual daily
 18 %
of total potential
Based on monthly moving average VanEck Vectors is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Vectors by adding it to a well-diversified portfolio.

Performance Rating

VanEck Vectors Biotech ETF Risk Adjusted Performance Analysis

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in VanEck Vectors Biotech ETF are ranked lower than 18 (%) of all global equities and portfolios over the last 30 days.

VanEck Vectors Alerts

Equity Alerts and Improvement Suggestions
The fund generated three year return of -4.0%
VanEck Vectors Biotech ETF holds all of its assets under management (AUM) in equities

VanEck Vectors Biotech Dividends Analysis

Check VanEck Vectors Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Check also Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.